About Strata Critical Medical, Inc.
http://www.stratacritical.comHoly City Straw Company is a sustainable brand delivering 100% plant-based disposable straws and cutlery to the foodservice industry. Their products are made from natural wheat and reed plant stems, offering biodegradable and compostable alternatives to plastic straws. They focus on eco-friendly, chemical-free production with minimal carbon footprint and are USDA BioPreferred certified.
CEO
Melissa Tomkiel
Compensation Summary
(Year )
Ratings Snapshot
Rating : C-
Price Target
About Strata Critical Medical, Inc.
http://www.stratacritical.comHoly City Straw Company is a sustainable brand delivering 100% plant-based disposable straws and cutlery to the foodservice industry. Their products are made from natural wheat and reed plant stems, offering biodegradable and compostable alternatives to plastic straws. They focus on eco-friendly, chemical-free production with minimal carbon footprint and are USDA BioPreferred certified.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $49.3M ▼ | $17.24M ▼ | $57.42M ▲ | 116.47% ▲ | $0.7 ▲ | $-9.24M ▼ |
| Q2-2025 | $70.8M ▲ | $22.69M ▲ | $-3.74M ▼ | -5.29% ▲ | $-0.05 ▼ | $-3.18M ▲ |
| Q1-2025 | $54.31M ▼ | $19.56M ▼ | $-3.49M ▲ | -6.43% ▲ | $-0.04 ▲ | $-5.89M ▲ |
| Q4-2024 | $54.36M ▼ | $20.96M ▼ | $-9.79M ▼ | -18.02% ▼ | $-0.12 ▼ | $-6.84M ▼ |
| Q3-2024 | $74.88M | $23.37M | $-1.95M | -2.61% | $-0.03 | $-2.26M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $75.92M ▼ | $335.08M ▲ | $52.08M ▲ | $283M ▲ |
| Q2-2025 | $113.42M ▼ | $257.92M ▲ | $34.82M ▲ | $223.1M ▲ |
| Q1-2025 | $120.01M ▼ | $250.55M ▼ | $30.82M ▼ | $219.73M ▼ |
| Q4-2024 | $127.14M ▼ | $256.68M ▼ | $34.74M ▼ | $221.94M ▼ |
| Q3-2024 | $136.34M | $282.94M | $49.45M | $233.5M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-9.66M ▼ | $-31.84M ▼ | $2.4M ▼ | $-7.24M ▼ | $-37.3M ▼ | $-34.97M ▼ |
| Q2-2025 | $-3.74M ▼ | $-4.21M ▲ | $28.68M ▲ | $14K ▼ | $24.63M ▲ | $-6.94M ▲ |
| Q1-2025 | $-3.49M ▲ | $-4.55M ▼ | $20.41M ▲ | $60K ▲ | $16.04M ▲ | $-7.7M ▼ |
| Q4-2024 | $-9.79M ▼ | $13K ▼ | $3.98M ▲ | $-5.64M ▼ | $-1.76M ▲ | $-5.03M ▼ |
| Q3-2024 | $-1.95M | $6.36M | $-12.65M | $-731K | $-6.96M | $-3.56M |
CEO
Melissa Tomkiel
Compensation Summary
(Year )
Ratings Snapshot
Rating : C-